Comparison of Efficacy of Ivabradine Versus Metoprolol

NCT01755663 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2014-10-29

No results posted yet for this study

Summary

Ivabradine may be better than Metoprolol for controlling heart rate before Coronary CTA.

Conditions

Interventions

DRUG

Ivabradine and Metoprolol

Sponsors & Collaborators

  • Phramongkutklao College of Medicine and Hospital

    collaborator OTHER
  • Col. Suthee Panichkul

    lead OTHER

Principal Investigators

  • Purich - Surunchupakorn, M.D. · Phramongkutklao College of Medicine and Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2014-12-31
Completion
2015-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01755663 on ClinicalTrials.gov